A case of false positive opiate immunoassay results from rifampin (rifampicin) treatment.

Pract Lab Med

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.

Published: November 2023

The drug screen test on a 12-year-old male patient was positive for opiates by a kinetic interaction of microparticles in solution (KIMS) immunoassay method on the Roche Cobas C502. The positive opiates result was not confirmed by the liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. A chart review revealed that the patient had tuberculosis and was on rifampin. We spiked rifampin into drug-free urine and tested opiates with the Cobas method. Once again, a positive result was obtained. This case showed that rifampin can still cause false positive opiate results measured with the KIMS method. We want to stress the importance of confirming positive screen results by more specific methods such as LC-MS/MS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498289PMC
http://dx.doi.org/10.1016/j.plabm.2023.e00334DOI Listing

Publication Analysis

Top Keywords

false positive
8
positive opiate
8
positive opiates
8
positive
6
case false
4
opiate immunoassay
4
rifampin
4
immunoassay rifampin
4
rifampin rifampicin
4
rifampicin treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!